TTR (Transthyretin) Stabilizers Are Associated With Improved Survival in Patients With TTR Cardiac Amyloidosis [Original Articles]

Conclusions:
TTR stabilizers are associated with decreased death and OHT in TTR cardiac amyloidosis. These results need to be confirmed by ongoing randomized clinical trials.

Source: Circulation: Heart Failure - April 3, 2018 Category: Cardiology Authors: Rosenblum, H., Castano, A., Alvarez, J., Goldsmith, J., Helmke, S., Maurer, M. S. Tags: Cardiomyopathy, Heart Failure Original Articles Source Type: research